Adrian Wiestner
5PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 17, 2025
A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.Andy Itsara, Victoria M Rogness, Laura Samples
|Apr 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta
|Jun 14, 2023
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy.Jennifer A Woyach, Paolo Ghia, John C Byrd
|May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.Anfal Alsadhan, Jonathan Chen, Erika M Gaglione
|May 23, 2023
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting.Maissa Mhibik, Erika M Gaglione, David Eik
Pageof 1
Frequent Collaborators
4 joint publications
Clare Sun
3 joint publications
Inhye E Ahn
2 joint publications
Erika M Gaglione
2 joint publications
Xin Tian
1 joint publications
Christopher Chiu
1 joint publications
Anfal Alsadhan
1 joint publications
Jonathan Chen
1 joint publications
Chingiz Underbayev
1 joint publications
Pamela L Tuma
1 joint publications
Lita A Freeman
